American Regent


ASP | WAC | AWP at the HCPCS Unit


American Regent

Injectafer HCPCS:


HCPCS Code Descriptor:

Injection, ferric carboxymaltose, 1 mg


J Code

Injectafer NDCs:

00517-0602-01, 00517-0650-01

Primary Type:


Generic/Specialty Status:


Package Type:


Route of Administration:


Injectafer CPT Codes:

-96374 - Therapeutic, prophylactic, or diagnostic injection (specify substance or drug) Intravenous push single or initial substance drug

-96365 - Intravenous infusion for therapy, prophylaxis, or diagnosis (specify substance or drug); initial up to 1 hr

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Injectafer:

INJECTAFER is an Anti-Anemia drug manufactured by American Regent and administered via the Intravenous route of administration. The J Code: J1439 is aligned to the drug INJECTAFER.

Injectafer is an intravenous form of iron replacement. Injectafer can be used to treat iron deficiency anemia, also known as IDA, for patients who have not responded well to oral forms of iron supplements. It can also be used to treat IDA in patients with non-dialysis dependent chronic kidney disease. With IV iron treatments such as injectafer, 100% of the iron they contain is delivered into the bloodstream, which may help patients who have had unsatisfactory responses to other iron replacement treatments.


J1439 Added Date:

January 1, 2015

J1439 Effective Date:

January 1, 2015

J1439 Termination Date:

HCPCS Active

Injectafer billing and coding information can be found through American Regent at the link below:
Injectafer patient assistance information can be found through American Regent’s VenAccess Program at the URL:
INJECTAFER prescribing information can be found at the link below:
Information regarding INJECTAFER’s side effects can be found at MedlinePlus